E. Mounetou

发表

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines

F. Penault-Llorca, Clémence Dubois, Pierre Daumar, 2019, Journal of clinical medicine.

Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy

S. Guerder, Clémence Dubois, Pierre Daumar, 2019, Journal of clinical medicine.

Cytotoxicity Study of Gold Nanoparticles on the Basal-Like Triple-Negative HCC-1937 Breast Cancer Cell Line

C. Massard, O. Awitor, Clémence Dubois, 2018 .

Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines

F. Penault-Llorca, Clémence Dubois, Pierre Daumar, 2017, Oncotarget.

New quaternary ammonium oxicam derivatives: synthesis and in vitro antiosteoarthritis evaluation.

J. Chezal, E. Mounetou, A. Vidal, 2010, European journal of medicinal chemistry.

N-4-iodophenyl-N′-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles

J. Madelmont, E. Miot-Noirault, R. Gaudreault, 2010, Investigational New Drugs.

N-(4-iodophenyl)-N′-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice

J. Madelmont, R. C.-Gaudreault, E. Miot-Noirault, 2007, British Journal of Cancer.

evelopment and validation of a high-performance liquid hromatography method for the quantitation of intracellular PARP nhibitor Olaparib in cancer cells

F. Penault-Llorca, Clémence Dubois, Pierre Daumar, 2018 .

Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.

P. Renard, J. Madelmont, E. Mounetou, 2007, Bioorganic & medicinal chemistry.

Alkylation of β-Tubulin on Glu 198 by a Microtubule Disrupter

J. Papon, J. Madelmont, E. Miot-Noirault, 2005, Molecular Pharmacology.

Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-Chloroethyl)Ureas

J. Madelmont, R. C.-Gaudreault, E. Miot-Noirault, 2004, Cancer Research.

A new generation of N-aryl-N'-(1-alkyl-2-chloroethyl)ureas as microtubule disrupters: synthesis, antiproliferative activity, and beta-tubulin alkylation kinetics.

J. Legault, E. Mounetou, J. Lacroix, 2003, Journal of medicinal chemistry.

Antimitotic antitumor agents: synthesis, structure-activity relationships, and biological characterization of N-aryl-N'-(2-chloroethyl)ureas as new selective alkylating agents.

R. C.-Gaudreault, J. Legault, E. Mounetou, 2001, Journal of medicinal chemistry.

Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.

P. Poyet, R. Gaudreault, S. Bolduc, 2000, Cancer research.

A Simple and Efficient Synthesis of Methyl 3,4-Dihydro-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide from Saccharin Sodium Salt

J. Madelmont, E. Mounetou, A. Vidal, 2006 .

Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma

N. Moins, J. Madelmont, E. Miot-Noirault, 2004, Investigational New Drugs.

Alkylation of (cid:1) -Tubulin on Glu 198 by a Microtubule Disrupter

J. Papon, J. Madelmont, E. Miot-Noirault, 2005 .

Adhesion-mediated Drug Resistance Agents Disrupting Microtubules That Are Unaffected by Cell Phenyl-3-(2-chloroethyl)ureas : a Class of Soft Alkylating Antiangiogenic and Antitumoral Activity of Cited Articles Citing Articles E-mail Alerts Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-chlor

J. Madelmont, R. C.-Gaudreault, E. Miot-Noirault, 2022 .

Antimitotic Antitumor Agents: Synthesis, Structure—Activity Relationships, and Biological Characterization of N-Aryl-N′-(2-chloroethyl)ureas as New Selective Alkylating Agents.

R. C.-Gaudreault, J. Legault, E. Mounetou, 2001 .

Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.

A. Veyre, J. Madelmont, J. Sauzieres, 1994, The Journal of pharmacology and experimental therapeutics.

A New O6-Alkylguanine-DNA Alkyltransferase Inhibitor Associated with a Nitrosourea (Cystemustine) Validates a Strategy of Melanoma-Targeted Therapy in Murine B16 and Human-Resistant M4Beu Melanoma Xenograft Models

J. Papon, J. Madelmont, A. Croisy, 2008, Journal of Pharmacology and Experimental Therapeutics.

PEGylation enhances the tumor selectivity of melanoma-targeted conjugates.

J. Chezal, S. Besse, E. Mounetou, 2015, Organic & biomolecular chemistry.

Spacer optimization of new conjugates for a melanoma-selective delivery approach.

J. Chezal, S. Tarrit, E. Débiton, 2013, Organic and biomolecular chemistry.

Optimization of Grignard ring-opening of α-brominated dioxolanes for the preparation of β-hydroxy-protected vinyl ethers by a three-step one-pot procedure

J. Chezal, M. Bayle, E. Mounetou, 2012 .

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib

C. Abrial, F. Kwiatkowski, F. Penault-Llorca, 2015, Scientific Reports.

Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.

A. Veyre, J. Madelmont, E. Débiton, 1997, British Journal of Cancer.

Synthesis of three no-carrier-added O6-4-[125I] iodobenzylguanosine derivatives, new reagents for the assay of O6-alkylguanine-DNA alkyltransferase activity

A. Veyre, J. Madelmont, M. Moreau, 1995 .

LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models

F. Penault-Llorca, Clémence Dubois, Pierre Daumar, 2021, Cancers.

The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids

F. Penault-Llorca, Clémence Dubois, Pierre Daumar, 2021, Cancers.

Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-Chloroethyl)Ureas

J. Madelmont, R. C.-Gaudreault, E. Miot-Noirault, 2004, Cancer Research.